Corporate Governance Compliance Report Not Applicable for Q2 FY27

Compliance View source PDF Explain this filing

NEPHROCARE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-1.4%Reaction day

₹90.95

prior close

₹89.20

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-1.3%-0.1% vs market

On the reaction day the stock moved 0.1 pts less than Nifty Microcap 250, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

-2.5

Sessions after the filingfrom the prior close

StockMarketvs market

Reaction day

-1.4-1.3-0.1

Next day

-5.4-1.3-4.2

-2.7+0.0-2.8

-7.1-0.2-6.9

-8.2-3.0-5.2

-7.7-2.7-5.0

-5.4-1.7-3.7

15d

-12.6-8.9-3.7

———

UpDownMarket · Nifty Microcap 250Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Nephro Care India has informed NSE that submitting the Corporate Governance Compliance Report for the quarter ended September 30, 2026 is not applicable to the company. Since the company is listed on the NSE EMERGE (SME) platform since July 2024, it is exempt under Regulation 15(2)(b) of SEBI LODR from corporate governance provisions. The company will continue to comply with other listing requirements as and when applicable.

Likely market impact

Routine regulatory filing. No material impact. Confirms an exemption that applies to all SME-listed companies.